National Certified Addiction Counselor, Level I (NCAC I) Practice Exam

Which statement is true about Zolpidem (Ambien)?

1. It is a barbiturate

2. It is commonly referred to as a benzodiazepine

3. It can be mistaken for benzodiazepines

4. It has a longer duration than benzodiazepines

The correct answer is: It can be mistaken for benzodiazepines

Zolpidem, commonly known by its brand name Ambien, is classified as a sedative-hypnotic medication primarily used for the treatment of insomnia. One critical aspect of its pharmacological profile is that while Zolpidem is not a benzodiazepine, its mechanism of action is similar, as it enhances the effects of the neurotransmitter gamma-aminobutyric acid (GABA). This similarity often leads to it being mistaken for benzodiazepines in terms of its effects and usage. Understanding the implications of this similarity is important because it affects how Zolpidem is perceived in clinical practice and among patients. Those taking it might inadvertently assume it carries the same risks and effects as benzodiazepines, which are often prescribed for anxiety and other disorders, rather than recognizing it as a distinct drug with its own profile and considerations. This clarification highlights the need for awareness regarding the differences in drug classifications and their corresponding effects, especially for healthcare providers prescribing these medications, as well as for patients managing their treatment options.